Nucleus® smart sound processing technology
Whether you’re in a restaurant, classroom or office, our latest Nucleus sound processors are designed to help you hear your best.
What you'll find on this page
- How our hearing technology adapts to your listening environment.
- How ForwardFocus technology is designed to help you hear speech in noise more clearly.
Experience your best hearing
We understand that hearing in different environments can be challenging. That's why our latest Nucleus® sound processors feature smarter hearing technology designed to make communicating with people easier, particularly in noise.*
As you move through the day, our sound processors sense changes in your listening environment and automatically adjusts your hearing settings using enhanced SmartSound® iQ 2 with SCAN 2 to help deliver clearer sound. Whether you're walking in the park on a windy day, sitting in a work meeting or chatting to friends in a noisy cafe, our advanced technology is designed to adapt to give you the best possible listening experience.1-4
When you want to focus on face-to-face conversations, an improved ForwardFocus powerfully reduces distracting background noise and can automatically adjust your level of noise reduction based on your surroundings.5,#
Hear your best no matter where you are, or where the day takes you.
Focus on what’s important
Feel part of every conversation and immerse yourself in each moment. Featuring enhanced ForwardFocus, our latest sound processors are designed to more powerfully reduce unwanted noise from behind you and can automatically adjust your level of noise reduction depending on your listening environment, so you can hear face to face conversations more clearly.1,5,#
ForwardFocus can also be user controlled or automated to help you focus on what's important in any situation.†
"With the Cochlear implant I don't have a problem understanding my family, my wife and my daughter."
- Mathias, Cochlear™ Nucleus® recipient
More information
Disclaimer
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
For a full list of Cochlear’s trademarks, please visit our Terms of Use page.
In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 5 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.
Any testimonial featured on this website is intended for an Australian audience only.
† ForwardFocus is a clinician-enabled feature that can be user-controlled or automated.
* Compared to Nucleus 6, Nucleus 7 and Kanso 2 sound processors.
# Compared to Nucleus® 7 Sound Processor with ForwardFocus on.
References
- Mauger SJ, et al. Clinical outcomes with the Kanso off-the-ear cochlear implant sound processor. Int J Audiol. 2017, Apr; 56(4): 267-276. [Sponsored by Cochlear].
- Mauger SJ, et al. Clinical evaluation of the Nucleus 6 cochlear implant system: performance improvements with SmartSound iQ. Int J Audiol. 2014, Aug; 53(8): 564-576. [Sponsored by Cochlear]
- Wolfe J, et al. Benefits of Adaptive Signal Processing in a Commercially Available Cochlear Implant Sound Processor. Otol Neurotol. 2015 Aug;36(7):1181-90.
- Cochlear Limited. D1864200 SCAN 2 Design Description. Apr 2022.
- Cochlear Limited. D1913968 Nucleus 8 Whitepaper. Apr 2023